Library

Trial publications Phase IIa placebo controlled study (NCT00654784) and open label extension study (NCT00758225) Efficacy and Tolerability of Idebenone in…

Brogna C, Lucibello S, Coratti G, et al. Respiratory function and therapeutic expectations in DMD: families experience and perspective. Acta…

McKim DA, Cripe TP, Cripe LH. The effect of emerging molecular and genetic therapies on cardiopulmonary disease in Duchenne muscular…

Cesareo A, LoMauro A, Santi M, Biffi E, D'Angelo MG, Aliverti A. Acute Effects of Mechanical Insufflation-Exsufflation on the Breathing…

Toussaint M, Pernet K, Steens M, Haan J, Sheers N. Cough Augmentation in Subjects With Duchenne Muscular Dystrophy: Comparison of…

Gogou M, Pavlou E, Haidopoulou K. Therapies that are available and under development for Duchenne muscular dystrophy: What about lung…

Crescimanno G, Greco F, Abbate A, Canino M, Bertini M, Marrone O. Subjective sleep quality in adult patients affected by…

Angliss ME, Sclip KD, Gauld L. Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated…

Mayer OH, Leinonen M, Rummey C, Meier T, Buyse GM, Group DS. Efficacy of Idebenone to Preserve Respiratory Function above Clinically…

Buyse GM, Voit T, Schara U, et al. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular…

McDonald CM, Meier T, Voit T, et al. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy. Neuromuscular disorders…